Cleared Traditional

K924721 - BAXTER SOLUTION ADMINISTRATION SETS

K924721 is an FDA 510(k) clearance for BAXTER SOLUTION ADMINISTRATION SETS, manufactured by Baxter Healthcare Corp. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 302-day FDA review.

K924721 · Baxter Healthcare Corp · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1993
Decision
302d
Days
Class 2
Risk

K924721 is an FDA 510(k) clearance for the BAXTER SOLUTION ADMINISTRATION SETS. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Round Lake, US). The FDA issued a Cleared decision on July 20, 1993 after a review of 302 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Baxter Healthcare Corp devices

FDA 510(k) Submission Details - K924721

510(k) Number K924721 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 1992
Decision Date July 20, 1993
Days to Decision 302 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
173d slower than avg
Panel avg: 129d · This submission: 302d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 791
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K924721.
IVAC 59 SERIES UNIVERSAL SET W/ ANTI-FREE FLOW VAL
K925228 · Y · Jul 1993
REPLACEMENT CAP
K930855 · Douglas Medical Products Corp. · Jul 1993
DOUGLAS MEDICAL PRODUCTS, INC. VENTED SPIKE ADAPT
K926184 · Douglas Medical Products Corp. · Jul 1993
SHROUDED NEEDLE DEVICES
K924718 · Imed Corp. · Jun 1993
INTERLINK(TM) INJECTION SITE
K925126 · Baxter Healthcare Corp · Jun 1993
AVI(TM) MODEL 232 STANDARD IV ADMINISTRATION SET
K924207 · 3M Health Care, Ltd. · May 1993